SPECIAL NOTICE
65 -- Mesenchymal Stem Cells
- Notice Date
- 11/29/2021 10:13:42 AM
- Notice Type
- Special Notice
- NAICS
- 621511
— Medical Laboratories
- Contracting Office
- W4PZ USA MED RSCH ACQUIS ACT FORT DETRICK MD 21702-5014 USA
- ZIP Code
- 21702-5014
- Solicitation Number
- W81XWH22Q0010
- Response Due
- 12/9/2021 7:00:00 AM
- Archive Date
- 12/24/2021
- Description
- THIS IS A NOTICE OF INTENT TO AWARD A SOLE-SOURCE CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE PROPOSALS. The U.S. Army Medical Research Acquisition Activity (USAMRAA) intends to award a sole source basis in accordance FAR 13.106-1(b)(1)(i) with RoosterBio, Inc. 5295 Westview Drive, Frederick, MD 21703, as the sole manufacturer and only responsible source that can provide commercial human bone marrow-derived mesenchymal stem cells (hMSC). �This acquisition is being conducted under FAR Part 12, Acquisition of Commercial Items.� Provisions and clauses in effect through Federal Acquisition Circular 2021-05 are incorporated. The Medical Readiness Systems Biology (MRSB) a division of the Military Psychiatry and Neuroscience (CMPN) at the Walter Reed Institute of Research is responsible for the development of evidence-based knowledge products and interventions to optimize the readiness and resilience of Soldiers across the deployment cycle.� The objective of MRSB is to facilitate a rapid and efficient transformation of biomedical knowledge to clinically actionable items. MRSB aims to deliver a comprehensive molecular etiology of disease dynamics towards developing precision care and systems medicine. MRSB�s ultimate goal is to improve the warfighters wellness, performance, resilience, and readiness. This requirement is to support MRSB current research to assess the efficacy of human bone marrow-derived mesenchymal stem cells (hMSC) to ameliorate the impact of cold shock in an effort to enhance cognitive and motor functions and improve overall performance. Items being included in this acquisition are: Six (6) 0.5L PBS Bioreactor with RoosterCollect- EV Pro (Upstream) Development Grade (Research Use Only grade) cells and media.� The RoosterBio, human bone marrow-derived mesenchymal stem cells (hMSC) must include Development Grade (Research Use Only grade) cells and media; preparation of the human bone marrow-derived mesenchymal stem cells (hMSC) ready for use within CPMN�s mouse model, low risk of batch-to-batch variability, purity and quality control the product. The intended acquisition will be classified under North American Industry Classification System (NAICS) 621511, Medical Laboratories, with a Small Business Size Standard of $22M dollars. This announcement fulfills the synopsis requirements under FAR 5.102(a)(3) and 5.203(a)(1). USAMRAA intends to release a solicitation no sooner than ten (10) days after publishing this synopsis. This Special Notice of Intent (NOI) is not a request for competitive quotes. Meaningful submissions received in response to this notice will be considered solely for the purpose of determining whether a competitive procurement is in the best interest of the Government. If no meaningful, written submissions are received by the date listed below, which reflects at least ten (10) days after the publication of this notice, the solicitation will be issued as a sole source requirement to RoosterBio, Inc. All questions and responses concerning this notice shall be emailed to Rebecca Wisner at rebecca.c.wisner.civ@mail.mil. Interested concerns must identify their capability in writing to the above e-mail address no later than 10:00 AM Eastern Daylight Time (EDT), 09 December 2021. No phone calls accepted.
- Web Link
-
SAM.gov Permalink
(https://beta.sam.gov/opp/9fafecc45aec4ba3bb0486a7f23d2424/view)
- Place of Performance
- Address: Frederick, MD 21702, USA
- Zip Code: 21702
- Country: USA
- Zip Code: 21702
- Record
- SN06186121-F 20211201/211129230114 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |